| Community reinforcement therapy for cocaine-dependent outpatients ST Higgins, SC Sigmon, CJ Wong, SH Heil, GJ Badger, R Donham, ... Archives of general psychiatry 60 (10), 1043-1052, 2003 | 272 | 2003 |
| Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial MR Lofwall, SL Walsh, EV Nunes, GL Bailey, SC Sigmon, KM Kampman, ... JAMA internal medicine 178 (6), 764-773, 2018 | 247 | 2018 |
| Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact JR Brooklyn, SC Sigmon Journal of addiction medicine 11 (4), 286-292, 2017 | 237 | 2017 |
| Access to treatment for opioid dependence in rural America: challenges and future directions SC Sigmon JAMA psychiatry 71 (4), 359-360, 2014 | 200 | 2014 |
| Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice SC Sigmon, A Bisaga, EV Nunes, PG O'Connor, T Kosten, G Woody The American journal of drug and alcohol abuse 38 (3), 187-199, 2012 | 143 | 2012 |
| Addiction potential of cigarettes with reduced nicotine content in populations with psychiatric disorders and other vulnerabilities to tobacco addiction ST Higgins, SH Heil, SC Sigmon, JW Tidey, DE Gaalema, JR Hughes, ... JAMA psychiatry 74 (10), 1056-1064, 2017 | 119 | 2017 |
| Characterizing the emerging population of prescription opioid abusers SC Sigmon American Journal on Addictions 15 (3), 208-212, 2006 | 111 | 2006 |
| The use of financial incentives in promoting smoking cessation SC Sigmon, ME Patrick Preventive medicine 55, S24-S32, 2012 | 110 | 2012 |
| Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective … SC Sigmon, RI Herning, W Better, JL Cadet, RR Griffiths Psychopharmacology 204, 573-585, 2009 | 109 | 2009 |
| Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. SC Sigmon, S Steingard, GJ Badger, SL Anthony, ST Higgins Experimental and Clinical Psychopharmacology 8 (4), 509, 2000 | 109 | 2000 |
| Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone RN Rosenthal, W Ling, P Casadonte, F Vocci, GL Bailey, K Kampman, ... Addiction 108 (12), 2141-2149, 2013 | 106 | 2013 |
| Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: a review of specific interventions KT Mueser, RE Drake, SC Sigmon, MF Brunette Journal of Dual Diagnosis 1 (2), 57-82, 2005 | 105 | 2005 |
| A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers SC Sigmon, KE Dunn, K Saulsgiver, ME Patrick, GJ Badger, SH Heil, ... JAMA psychiatry 70 (12), 1347-1354, 2013 | 96 | 2013 |
| Incentives and health: an introduction ST Higgins, K Silverman, SC Sigmon, NA Naito Preventive medicine 55, S2-S6, 2012 | 92 | 2012 |
| Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness SC Sigmon, ST Higgins Journal of Substance Abuse Treatment 30 (4), 291-295, 2006 | 85 | 2006 |
| Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting KE Dunn, FS Barrett, C Yepez-Laubach, AC Meyer, BJ Hruska, K Petrush, ... Journal of substance abuse treatment 71, 1-7, 2016 | 84 | 2016 |
| Interim buprenorphine vs. waiting list for opioid dependence SC Sigmon, TA Ochalek, AC Meyer, B Hruska, SH Heil, GJ Badger, ... New England Journal of Medicine 375 (25), 2504-2505, 2016 | 82 | 2016 |
| A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. KE Dunn, SC Sigmon, EF Reimann, GJ Badger, SH Heil, ST Higgins Experimental and clinical psychopharmacology 18 (1), 37, 2010 | 80 | 2010 |
| The untapped potential of office-based buprenorphine treatment SC Sigmon JAMA psychiatry 72 (4), 395-396, 2015 | 79 | 2015 |
| Increases in body mass index following initiation of methadone treatment JM Fenn, JS Laurent, SC Sigmon Journal of substance abuse treatment 51, 59-63, 2015 | 74 | 2015 |
